Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
Narula, Neeraj
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium. [electronic resource] - The American journal of gastroenterology 09 2018 - 1345 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1572-0241
10.1038/s41395-018-0162-0 doi
Adult
Antibodies, Monoclonal, Humanized--therapeutic use
Colectomy--statistics & numerical data
Colitis, Ulcerative--diagnosis
Colon--diagnostic imaging
Colonoscopy
Female
Follow-Up Studies
Gastrointestinal Agents--therapeutic use
Glucocorticoids--therapeutic use
Humans
Infections--epidemiology
Male
Middle Aged
Registries--statistics & numerical data
Remission Induction--methods
Retrospective Studies
Severity of Illness Index
Treatment Outcome
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium. [electronic resource] - The American journal of gastroenterology 09 2018 - 1345 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1572-0241
10.1038/s41395-018-0162-0 doi
Adult
Antibodies, Monoclonal, Humanized--therapeutic use
Colectomy--statistics & numerical data
Colitis, Ulcerative--diagnosis
Colon--diagnostic imaging
Colonoscopy
Female
Follow-Up Studies
Gastrointestinal Agents--therapeutic use
Glucocorticoids--therapeutic use
Humans
Infections--epidemiology
Male
Middle Aged
Registries--statistics & numerical data
Remission Induction--methods
Retrospective Studies
Severity of Illness Index
Treatment Outcome
Tumor Necrosis Factor-alpha--antagonists & inhibitors